Babies, Blemishes and FDA: A History of Accutane Regulation in the United States

DSpace/Manakin Repository

Babies, Blemishes and FDA: A History of Accutane Regulation in the United States

Show simple item record

dc.contributor.advisor Hutt, Peter Barton en_US
dc.contributor.author Green, Julia en_US
dc.date.accessioned 2012-07-06T20:09:14Z
dc.date.issued 2002 en_US
dc.identifier.citation Babies, Blemishes and FDA: A History of Accutane Regulation in the United States (2002 Third Year Paper) en
dc.identifier.uri http://nrs.harvard.edu/urn-3:HUL.InstRepos:8963867
dc.description.abstract This paper takes a journalistic approach, tracing the chronology of Accutane in the U.S. in order to fill in the gaps of the story that has inspired so much controversy. Accutane has repeatedly pushed the frontier of FDA regulation, as the agency struggled to adapt its tools to meet the challenge of an extremely effective and extremely dangerous medication. By emphasizing the evolving American response to the high level of risk associated with Accutane, I hope to provide the material needed to evaluate the strengths and weaknesses of our current regulatory framework. en
dc.language.iso en_US en
dash.license LAA en_US
dc.subject Food and Drug Law en
dc.subject Accutane en
dc.subject FDA en
dc.subject dangers en
dc.subject birth en
dc.subject defects en
dc.title Babies, Blemishes and FDA: A History of Accutane Regulation in the United States en
dc.type Paper (for course/seminar/workshop) en_US
dc.date.available 2012-07-06T20:09:14Z

Files in this item

Files Size Format View
Green.pdf 196.8Kb PDF View/Open
Green.rtf 138.7Kb RTF file View/Open
Green.html 126.9Kb HTML View/Open

This item appears in the following Collection(s)

Show simple item record

 
 

Search DASH


Advanced Search
 
 

Submitters